Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2497
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    51,212.02
    -640.74 (-1.24%)
     
  • CMC Crypto 200

    1,333.76
    -62.77 (-4.50%)
     
  • S&P 500

    5,105.40
    +56.98 (+1.13%)
     
  • DOW

    38,286.11
    +200.31 (+0.53%)
     
  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,351.30
    +8.80 (+0.38%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Why Moderna Stock Is Rising Today

Why Moderna Stock Is Rising Today

Shares of Moderna (NASDAQ: MRNA) were rising 3.3% as of 10:59 a.m. EDT on Monday. This gain came after the Financial Times reported new forecasts from health data analytics company Airfinity that project Moderna's COVID-19 vaccine could generate sales of $38.7 billion in 2022. Investors might be justified in jumping aboard the Moderna train if Airfinity's 2022 estimate is right.